Ausgabe 2/2011
Inhalt (36 Artikel)
Aromatase inhibitor-associated bone and musculoskeletal effects: new evidence defining etiology and strategies for management
Stéphanie Gaillard, Vered Stearns
Nanomedicine: making controllable magnetic drug delivery possible for the treatment of breast cancer
Lesa A Tran, Lon J Wilson
Signaling pathways in breast cancer metastasis - novel insights from functional genomics
Mario Andres Blanco, Yibin Kang
Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer
Bethany N Hannafon, Paola Sebastiani, Antonio de las Morenas, Jining Lu, Carol L Rosenberg
Impact of oncogenic K-RASon YB-1 phosphorylation induced by ionizing radiation
Mahmoud Toulany, Tim-Andre Schickfluß, Wolfgang Eicheler, Rainer Kehlbach, Birgit Schittek, H Peter Rodemann
Fulvestrant-induced expression of ErbB3 and ErbB4 receptors sensitizes oestrogen receptor-positive breast cancer cells to heregulin β1
Iain R Hutcheson, Lindy Goddard, Denise Barrow, Richard A McClelland, Hayley E Francies, Janice M Knowlden, Robert I Nicholson, Julia MW Gee
Stratifying triple-negative breast cancer: which definition(s) to use?
Barbara Adamo, Carey K Anders
Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer
Cesar G Sanchez, Cynthia X Ma, Robert J Crowder, Therese Guintoli, Chanpheng Phommaly, Feng Gao, Li Lin, Matthew J Ellis
Alternative TFAP2A isoforms have distinct activities in breast cancer
Chiara Berlato, KaYi V Chan, Anna M Price, Monica Canosa, Angelo G Scibetta, Helen C Hurst
Cell fate takes a slug in BRCA1-associated breast cancer
Geoffrey J Lindeman, Jane E Visvader
Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis
Ola Blixt, Deanna Bueti, Brian Burford, Diane Allen, Sylvain Julien, Michael Hollingsworth, Alex Gammerman, Ian Fentiman, Joyce Taylor-Papadimitriou, Joy M Burchell
Pro-oncogene Pokemon promotes breast cancer progression by upregulating survivin expression
Xuyu Zu, Jun Ma, Hongxia Liu, Feng Liu, Chunyan Tan, Lingling Yu, Jue Wang, Zhenhua Xie, Deliang Cao, Yuyang Jiang
Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifen
Xianglin Wu, Malayannan Subramaniam, Sarah B Grygo, Zhifu Sun, Vivian Negron, Wilma L Lingle, Matthew P Goetz, James N Ingle, Thomas C Spelsberg, John R Hawse
Breast cancer cell migration is regulated through junctional adhesion molecule-A-mediated activation of Rap1 GTPase
Elaine A McSherry, Kieran Brennan, Lance Hudson, Arnold DK Hill, Ann M Hopkins
Estrogen receptor beta inhibits transcriptional activity of hypoxia inducible factor-1 through the downregulation of arylhydrocarbon receptor nuclear translocator
Wonchung Lim, Yeomyung Park, Jungyoon Cho, Choa Park, Joonwoo Park, Young-Kwon Park, Hyunsung Park, YoungJoo Lee
The indole-3-carbinol cyclic tetrameric derivative CTet inhibits cell proliferation via overexpression of p21/CDKN1A in both estrogen receptor-positive and triple-negative breast cancer cell lines
Mauro De Santi, Luca Galluzzi, Simone Lucarini, Maria Filomena Paoletti, Alessandra Fraternale, Andrea Duranti, Cinzia De Marco, Mirco Fanelli, Nadia Zaffaroni, Giorgio Brandi, Mauro Magnani
Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice
Laura N Burga, Hai Hu, Ashish Juvekar, Nadine M Tung, Susan L Troyan, Erin W Hofstatter, Gerburg M Wulf
Synergy between inhibitors of androgen receptor and MEK has therapeutic implications in estrogen receptor-negative breast cancer
Ali Naderi, Kee Ming Chia, Ji Liu
Second malignancies in breast cancer patients following radiotherapy: a study in Florence, Italy
Wei Zhang, Aldo Becciolini, Annibale Biggeri, Paolo Pacini, Colin R Muirhead
miR-24-2 controls H2AFX expression regardless of gene copy number alteration and induces apoptosis by targeting antiapoptotic gene BCL-2: a potential for therapeutic intervention
Niloo Srivastava, Siddharth Manvati, Archita Srivastava, Ranjana Pal, Ponnusamy Kalaiarasan, Shilpi Chattopadhyay, Sailesh Gochhait, Raina Dua, Rameshwar NK Bamezai
Adipokines, insulin resistance, metabolic syndrome, and breast cancer recurrence: a cohort study
Sang Woo Oh, Cheol-Young Park, Eun Sook Lee, Yeong Sook Yoon, Eon Sook Lee, Sang Shin Park, Yuil Kim, Nak Jin Sung, Young Ho Yun, Keun Seok Lee, Han Sung Kang, Youngmee Kwon, Jungsil Ro
Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapy
Yvonne Hui-Fang Teng, Wai-Jin Tan, Aye-Aye Thike, Poh-Yian Cheok, Gary Man-Kit Tse, Nan-Soon Wong, George Wai-Cheong Yip, Boon-Huat Bay, Puay-Hoon Tan
Stress and breast cancer: from epidemiology to molecular biology
Lilia Antonova, Kristan Aronson, Christopher R Mueller
More on FOX News: FOXA1 on the horizon of estrogen receptor function and endocrine response
Xiaoyong Fu, Catherine Huang, Rachel Schiff
The association of polymorphisms in hormone metabolism pathway genes, menopausal hormone therapy, and breast cancer risk: a nested case-control study in the California Teachers Study cohort
Eunjung Lee, Fredrick Schumacher, Juan Pablo Lewinger, Susan L Neuhausen, Hoda Anton-Culver, Pamela L Horn-Ross, Katherine D Henderson, Argyrios Ziogas, David Van Den Berg, Leslie Bernstein, Giske Ursin
Prospective isolation and characterization of committed and multipotent progenitors from immortalized mouse mammary epithelial cells with morphogenic potential
Frances S Kittrell, Martha Z Carletti, Sofia Kerbawy, Jessica Heestand, Wa Xian, Mei Zhang, Heather L LaMarca, Arnoud Sonnenberg, Jeffrey M Rosen, Daniel Medina, Fariba Behbod
Trastuzumab-DM1 causes tumour growth inhibition by mitotic catastrophe in trastuzumab-resistant breast cancer cells in vivo
Mark Barok, Minna Tanner, Katri Köninki, Jorma Isola
Exploring the link between MORF4L1 and risk of breast cancer
Griselda Martrat, Christopher A Maxwell, Emiko Tominaga, Montserrat Porta-de-la-Riva, Núria Bonifaci, Laia Gómez-Baldó, Massimo Bogliolo, Conxi Lázaro, Ignacio Blanco, Joan Brunet, Helena Aguilar, Juana Fernández-Rodríguez, Sheila Seal, Anthony Renwick, Nazneen Rahman, Julia Kühl, Kornelia Neveling, Detlev Schindler, María J Ramírez, María Castellà, Gonzalo Hernández, Douglas F Easton, Susan Peock, Margaret Cook, Clare T Oliver, Debra Frost, Radka Platte, D Gareth Evans, Fiona Lalloo, Rosalind Eeles, Louise Izatt, Carol Chu, Rosemarie Davidson, Kai-Ren Ong, Jackie Cook, Fiona Douglas, Shirley Hodgson, Carole Brewer, Patrick J Morrison, Mary Porteous, Paolo Peterlongo, Siranoush Manoukian, Bernard Peissel, Daniela Zaffaroni, Gaia Roversi, Monica Barile, Alessandra Viel, Barbara Pasini, Laura Ottini, Anna Laura Putignano, Antonella Savarese, Loris Bernard, Paolo Radice, Sue Healey, Amanda Spurdle, Xiaoqing Chen, Jonathan Beesley, Matti A Rookus, Senno Verhoef, Madeleine A Tilanus-Linthorst, Maaike P Vreeswijk, Christi J Asperen, Danielle Bodmer, Margreet GEM Ausems, Theo A van Os, Marinus J Blok, Hanne EJ Meijers-Heijboer, Frans BL Hogervorst, David E Goldgar, Saundra Buys, Esther M John, Alexander Miron, Melissa Southey, Mary B Daly, Katja Harbst, Åke Borg, Johanna Rantala, Gisela Barbany-Bustinza, Hans Ehrencrona, Marie Stenmark-Askmalm, Bella Kaufman, Yael Laitman, Roni Milgrom, Eitan Friedman, Susan M Domchek, Katherine L Nathanson, Timothy R Rebbeck, Oskar Thor Johannsson, Fergus J Couch, Xianshu Wang, Zachary Fredericksen, Daniel Cuadras, Víctor Moreno, Friederike K Pientka, Reinhard Depping, Trinidad Caldés, Ana Osorio, Javier Benítez, Juan Bueren, Tuomas Heikkinen, Heli Nevanlinna, Ute Hamann, Diana Torres, Maria Adelaide Caligo, Andrew K Godwin, Evgeny N Imyanitov, Ramunas Janavicius, Olga M Sinilnikova, Dominique Stoppa-Lyonnet, Sylvie Mazoyer, Carole Verny-Pierre, Laurent Castera, Antoine de Pauw, Yves-Jean Bignon, Nancy Uhrhammer, Jean-Philippe Peyrat, Philippe Vennin, Sandra Fert Ferrer, Marie-Agnès Collonge-Rame, Isabelle Mortemousque, Lesley McGuffog, Georgia Chenevix-Trench, Olivia M Pereira-Smith, Antonis C Antoniou, Julián Cerón, Kaoru Tominaga, Jordi Surrallés, Miguel Angel Pujana
Genetic variation in PRL and PRLR, and relationships with serum prolactin levels and breast cancer risk: results from a population-based case-control study in Poland
Sarah J Nyante, Jessica M Faupel-Badger, Mark E Sherman, Ruth M Pfeiffer, Mia M Gaudet, Roni T Falk, Abegail A Andaya, Jolanta Lissowska, Louise A Brinton, Beata Peplonska, Barbara K Vonderhaar, Stephen Chanock, Montserrat Garcia-Closas, Jonine D Figueroa
Estrogen receptor β represses Akt signaling in breast cancer cells via downregulation of HER2/HER3 and upregulation of PTEN: implications for tamoxifen sensitivity
Karolina Lindberg, Luisa A Helguero, Yoko Omoto, Jan-Åke Gustafsson, Lars-Arne Haldosén
Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancers
Max Yan, Nicholas Jene, David Byrne, Ewan KA Millar, Sandra A O'Toole, Catriona M McNeil, Gaynor J Bates, Adrian L Harris, Alison H Banham, Robert L Sutherland, Stephen B Fox
Targets of miR-200c mediate suppression of cell motility and anoikis resistance
Erin N Howe, Dawn R Cochrane, Jennifer K Richer
Quantitative assays for the measurement of HER1-HER2 heterodimerization and phosphorylation in cell lines and breast tumors: applications for diagnostics and targeted drug mechanism of action
Lisa DeFazio-Eli, Kristi Strommen, Trang Dao-Pick, Gordon Parry, Laurie Goodman, John Winslow
Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis
Bhumsuk Keam, Seock-Ah Im, Kyung-Hun Lee, Sae-Won Han, Do-Youn Oh, Jee Hyun Kim, Se-Hoon Lee, Wonshik Han, Dong-Wan Kim, Tae-You Kim, In Ae Park, Dong-Young Noh, Dae Seog Heo, Yung-Jue Bang